Detalhe da pesquisa
1.
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies.
Immunity
; 56(1): 193-206.e7, 2023 01 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36574772
2.
HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies.
J Virol
; 96(14): e0032422, 2022 07 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35758668
3.
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Nature
; 509(7498): 55-62, 2014 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24590074
4.
Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.
PLoS Pathog
; 13(1): e1006074, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28076415
5.
Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
PLoS Pathog
; 13(9): e1006641, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28945784
6.
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
PLoS Pathog
; 12(7): e1005742, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27434311
7.
HIV-1 Superinfection Resembles Primary Infection.
J Infect Dis
; 212(6): 904-8, 2015 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25754982
8.
Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.
J Infect Dis
; 211(9): 1461-6, 2015 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25398460
9.
South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4ß7 for replication.
Retrovirology
; 12: 54, 2015 Jun 24.
Artigo
Inglês
| MEDLINE | ID: mdl-26105197
10.
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies.
Cell Rep Med
; : 101577, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38761799
11.
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2.
NPJ Vaccines
; 9(1): 17, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38245545
12.
Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses.
Front Virol
; 3: 1128253, 2023 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37041983
13.
Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clones.
JCI Insight
; 8(1)2023 01 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36445762
14.
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages.
Nat Commun
; 14(1): 2249, 2023 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37076511
15.
SARS-CoV-2 evolution in the Omicron era.
Nat Microbiol
; 8(11): 1952-1959, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37845314
16.
SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses.
Front Immunol
; 14: 941281, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36756130
17.
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes.
Cell Rep Med
; 4(11): 101267, 2023 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37935199
18.
Vaccine-induced correlate of protection against fatal COVID-19 in older and frail adults during waves of neutralization-resistant variants of concern: an observational study.
Lancet Reg Health Eur
; : 100646, 2023 May 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37363799
19.
Antigen receptor stimulation induces purifying selection against pathogenic mitochondrial tRNA mutations.
JCI Insight
; 8(17)2023 09 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37681412
20.
Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactant.
Front Bioeng Biotechnol
; 10: 1083232, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36578508